EUVIMEDEUVIMED entdecken
Crossref

Cardiac Perioperative MACE: Could Ranolazine Safely Reduce it >35%?

Gary L. Murray

Journal of Thoracic Disease and Cardiothoracic Surgery · 2020

DOI: 10.31579/2693-2156/002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thoracic Disease and Cardiothoracic Surgery, 2020. Verfasst von Gary L. Murray.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Society of Thoracic Surgery Score and Euro II Score are tools for estimating major adverse cardiac events (MACE [death {or morbidity}, renal failure, stroke, prolonged ventilation, CSW infection, reoperation, prolonged admission]) after cardiac surgery.

Zitieren

APA

Murray, G. L. (2020). Cardiac Perioperative MACE: Could Ranolazine Safely Reduce it >35%?. Journal of Thoracic Disease and Cardiothoracic Surgery. https://doi.org/10.31579/2693-2156/002

Vancouver

Murray GL. Cardiac Perioperative MACE: Could Ranolazine Safely Reduce it >35%?. Journal of Thoracic Disease and Cardiothoracic Surgery. 2020. doi:10.31579/2693-2156/002

BibTeX
@article{Murray2020,
  author = {Murray, Gary L.},
  title = {Cardiac Perioperative MACE: Could Ranolazine Safely Reduce it >35%?},
  journal = {Journal of Thoracic Disease and Cardiothoracic Surgery},
  year = {2020},
  doi = {10.31579/2693-2156/002}
}
Kostenlos starten →